
Abstract 2139: Evaluation of a novel hypoxia-activated prodrug strategy in colorectal cancer cells
Author(s) -
Omar Hussain,
Henrik Johansson,
Simon J. Allison,
Daniel Sejer Pedersen,
Roger M. Phillips
Publication year - 2018
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2018-2139
Subject(s) - prodrug , hypoxia (environmental) , chemistry , colorectal cancer , ic50 , pharmacology , cancer cell , cancer , cell culture , toxicity , cancer research , biochemistry , medicine , in vitro , biology , oxygen , organic chemistry , genetics